Cwm, LLC Ironwood Pharmaceuticals Inc Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Cwm, LLC holds 3,942 shares of IRWD stock, worth $17,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,942

Previous 6,600 40.27%

Holding current value

$17,463

Previous $43,000 62.79%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$3.93 - $7.04 $10,445 - $18,712	-2,658 Reduced 40.27%	3,942 $16,000
Q2 2024 Jul 09, 2024	BUY	$5.58 - $8.61 $13,085 - $20,190	2,345 Added 55.11%	6,600 $43,000
Q1 2024 Apr 05, 2024	BUY	$8.32 - $15.45 $27,872 - $51,757	3,350 Added 370.17%	4,255 $37,000
Q4 2023 Feb 01, 2024	BUY	$8.79 - $11.51 $2,804 - $3,671	319 Added 54.44%	905 $10,000
Q3 2023 Oct 11, 2023	SELL	$8.25 - $11.35 $6,096 - $8,387	-739 Reduced 55.77%	586 $6,000
Q2 2023 Aug 03, 2023	BUY	$10.1 - $11.6 $8,888 - $10,208	880 Added 197.75%	1,325 $14,000
Q1 2023 Apr 28, 2023	BUY	$10.37 - $12.56 $642 - $778	62 Added 16.19%	445 $5,000
Q4 2022 Feb 01, 2023	BUY	$9.9 - $12.43 $49 - $62	5 Added 1.32%	383 $5,000
Q3 2022 Oct 27, 2022	BUY	$10.14 - $12.38 $3,234 - $3,949	319 Added 540.68%	378 $4,000
Q2 2022 Jul 28, 2022	BUY	$11.05 - $12.72 $320 - $368	29 Added 96.67%	59 $1,000
Q1 2022 Apr 21, 2022	SELL	$10.61 - $12.88 $31,235 - $37,918	-2,944 Reduced 98.99%	30 $0
Q1 2020 Apr 28, 2020	SELL	$8.58 - $14.01 $1,364 - $2,227	-159 Reduced 5.08%	2,974 $30,000
Q4 2019 Jan 27, 2020	BUY	$8.22 - $14.0 $1,306 - $2,226	159 Added 5.35%	3,133 $42,000
Q4 2018 Jan 25, 2019	BUY	$7.8 - $16.13 $23,197 - $47,970	2,974 New	2,974 $31,000

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $679M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account